PHP
BCEL

Parkman Healthcare Partners’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Parkman Healthcare Partners’s Portfolio BCEL Stock Details BCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100,628
Closed -$857K – 86
2021
Q2 		$857K Sell
100,628
-51,365
-34% -$526K 0.19% 75
2021
Q1 		$2.33M Buy
151,993
+25,735
+20% +$418K 0.54% 50
2020
Q4 		$2.04M Buy
126,258
+91,258
+261% +$1.37M 0.52% 58
2020
Q3 		$489K Buy
+35,000
New +$522K 0.13% 80

Other funds holding BCEL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkman Healthcare Partners's BCEL Position: Q3 2021 in Review

Parkman Healthcare Partners sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q3 2021, closing a stake of 100,628 shares — an estimated $857K sold.

Parkman Healthcare Partners first reported a position in BCEL in Q3 2020 and held it in 4 quarters. The position peaked at $2.33M in Q1 2021. 107 funds tracked by Wall St. Rank hold BCEL as of Q3 2021.

  • Parkman Healthcare Partners reported no remaining Atreca, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
  • Parkman Healthcare Partners sold 100,628 Atreca, Inc. Class A Common Stock shares in Q3 2021, an estimated $857K.
  • Parkman Healthcare Partners first reported a position in Atreca, Inc. Class A Common Stock in Q3 2020 and held it in 4 quarters.
  • Parkman Healthcare Partners's Atreca, Inc. Class A Common Stock position peaked at $2.33M in Q1 2021.
  • 107 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q3 2021.

Based on Parkman Healthcare Partners's 13F filing for Q3 2021, filed 12 Nov 2021.